SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-19-000330
Accepted
2019-02-28 00:15:13
Documents
1
Effectiveness Date
2019-02-27
Registration Form
POS AM
Reference AccNo
0001144204-19-008163

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 609
  Complete submission text file 9999999995-19-000330.txt   1787
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: EFFECT | Act: 33 | File No.: 333-209011 | Film No.: 19640244
SIC: 2836 Biological Products, (No Diagnostic Substances)